Hyperhomocysteinemia and impaired vasomotor function in type 2 diabetes mellitus
- 16 May 2002
- journal article
- research article
- Published by Wiley in European Journal of Clinical Investigation
- Vol. 32 (5) , 328-334
Abstract
Background Hyperhomocysteinemia has been shown to adversely affect vascular function. The aim of this study was to determine whether hyperhomocysteinemia was independently associated with changes in endothelium‐dependent and ‐independent vasomotor functions in patients with type 2 diabetes mellitus.Materials and methods Fasting homocysteine (tHcy) was measured in 123 patients with type 2 diabetes and in 61 nondiabetic controls. Endothelium‐dependent and ‐independent vasodilation was measured using high‐resolution vascular ultrasound.Results Plasma tHcy concentration was increased in the diabetic patients (11·1 ± 3·7 µmol L−1 vs. 9·8 ± 2·9, P < 0·05). The prevalence of hyperhomocysteinemia (defined as tHcy > 15 µmol L−1) was higher in the diabetic patients (P < 0·05). Within group comparisons showed that both the abnormalities in endothelium‐dependent and ‐independent vasodilation were significantly more severe in diabetic patients with tHcy 10–15 (P < 0·05) and tHcy > 15 µmol L−1 (P < 0·05) than in those patients with tHcy < 10 µmol L−1. When compared with nondiabetic controls matched for tHcy levels, impairment of endothelium‐dependent and ‐independent vasodilation were already evident, even in patients with normal tHcy levels (P < 0·01). Despite significant univariate relationships between tHcy and endothelium‐dependent (r = −0·24, P < 0·01) and ‐independent vasodilation (r = −0·33, P < 0·01) in patients with diabetes, only the relationship between tHcy and endothelium‐independent vasodilation remained significant after adjusting for other cardiovascular risk factors in multiple regression analysis.Conclusions Impairment of endothelium‐dependent and ‐independent vasodilation was already present in diabetic patients with normal tHcy levels, and these abnormalities became more severe with increasing tHcy levels. Only the association between tHcy and endothelium‐independent vasodilation was free of other cardiovascular risk factors.Keywords
This publication has 31 references indexed in Scilit:
- Hyperhomocysteinemia, Vascular Pathology, and Endothelial DysfunctionSeminars in Thrombosis and Hemostasis, 2000
- Homocysteine stimulates nuclear factor κB activity and monocyte chemoattractant protein-1 expression in vascular smooth-muscle cells: a possible role for protein kinase CBiochemical Journal, 2000
- Serum homocysteine is weakly associated with von Willebrand factor and soluble vascular cell adhesion molecule 1, but not with C‐reactive protein in type 2 diabetic and non‐diabetic subjects — The Hoorn StudyEuropean Journal of Clinical Investigation, 2000
- Endothelial dysfunction by acute hyperhomocyst(e)inaemia: restoration by folic acidClinical Science, 1999
- Plasma homocysteine concentration predicts mortality in non-insulin-dependent diabetic patients with and without albuminuriaKidney International, 1999
- Hyperhomocysteinemia Is Associated With an Increased Risk of Cardiovascular Disease, Especially in Non–Insulin-Dependent Diabetes MellitusArteriosclerosis, Thrombosis, and Vascular Biology, 1998
- Homocysteine and coronary atherosclerosisJACC, 1996
- Adverse vascular effects of homocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogen.Journal of Clinical Investigation, 1993
- Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosisThe Lancet, 1992
- Hyperhomocysteinemia: An Independent Risk Factor for Vascular DiseaseNew England Journal of Medicine, 1991